025466673	025466673	CD	B-NP	O
|	|	NN	I-NP	O
PAMC	PAMC	NN	I-NP	O
|	|	NN	I-NP	O
26506748	26506748	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
1086179	1086179	CD	B-NP	O
|	|	CC	I-NP	O
7/4/2005	7/4/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
viral	viral	JJ	I-NP	O
URI	URI	NN	I-NP	O
,	,	,	O	O
pulmonary	pulmonary	JJ	B-NP	O
HTN	HTN	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/18/2005	5/18/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/28/2005	3/28/2005	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
LIBRIZZI	LIBRIZZI	NNP	B-NP	O
,	,	,	O	O
MARIANO	MARIANO	NNP	B-NP	O
688-81-95-0	688-81-95-0	CD	I-NP	O
New	New	NNP	I-NP	O
Hi	Hi	NNP	I-NP	O
A	A	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
2/21/05	2/21/05	CD	B-NP	O
AT	AT	NN	I-NP	O
08	08	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
CADENAS	CADENAS	NNP	B-NP	O
,	,	,	O	O
HONG	HONG	NNP	B-NP	O
BROOKS	BROOKS	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
DISPOSITION	DISPOSITION	NNP	I-NP	O
:	:	:	O	O
Home	Home	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ECASA	ECASA	NN	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
81	81	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/25/05	5/25/05	CD	B-NP	O
by	by	IN	B-PP	O
LEVER	LEVER	NNP	B-NP	O
,	,	,	O	O
DARYL	DARYL	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
COLACE	COLACE	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
LASIX	LASIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
160	160	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
GLIPIZIDE	GLIPIZIDE	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
OCEAN	OCEAN	NNP	I-NP	O
SPRAY	SPRAY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
0.65	0.65	CD	I-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
2	2	CD	I-NP	O
SPRAY	SPRAY	NN	I-NP	O
NA	NA	NN	I-NP	O
QID	QID	NN	I-NP	O
PRN	PRN	NN	I-NP	O
Other	Other	JJ	B-ADJP	O
:	:	:	O	O
dried	dry	VBD	B-VP	O
nasal	nasal	JJ	B-NP	O
mucosa	mucosa	NN	I-NP	O
COUMADIN	COUMADIN	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
NOW	NOW	NNP	I-NP	O
,	,	,	O	O
Within	Within	NNP	B-NP	O
Hour	Hour	NNP	I-NP	O
of	of	IN	B-PP	O
Pharmacy	Pharmacy	NNP	B-NP	O
Approval	Approval	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
5/25/05	5/25/05	CD	B-NP	O
by	by	IN	B-PP	O
JERICH	JERICH	NN	B-NP	O
,	,	,	O	O
JOSPEH	JOSPEH	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ECASA	ECASA	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
74560509	74560509	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
ZOLOFT	ZOLOFT	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
SERTRALINE	SERTRALINE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
150	150	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
AMBIEN	AMBIEN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ZOLPIDEM	ZOLPIDEM	NN	I-NP	O
TARTRATE	TARTRATE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-SBAR	O
food	food	NN	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
KCL	KCL	NNP	I-NP	O
SLOW	SLOW	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
20	20	CD	I-NP	O
MEQ	MEQ	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
As	As	IN	B-PP	O
per	per	IN	B-PP	O
L	L	NNP	B-NP	O
Potassium	Potassium	NNP	I-NP	O
Chloride	Chloride	NNP	I-NP	O
Policy	Policy	NNP	I-NP	O
:	:	:	O	O
each	each	DT	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
with	with	IN	B-PP	O
4	4	CD	B-NP	O
oz	oz	NN	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	O
ATROVENT	ATROVENT	NN	I-NP	O
NASAL	NASAL	NNP	B-NP	O
0.06	0.06	CD	I-NP	O
%	%	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
IPRATROPIUM	IPRATROPIUM	NNP	I-NP	O
NASAL	NASAL	NNP	I-NP	O
0.06	0.06	CD	I-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
2	2	CD	I-NP	O
SPRAY	SPRAY	NN	I-NP	O
NA	NA	NN	I-NP	O
TID	TID	NN	I-NP	O
Number	Number	NN	I-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
NEXIUM	NEXIUM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
TRACLEER	TRACLEER	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
BOSENTAN	BOSENTAN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
125	125	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
VENTAVIS	VENTAVIS	NN	I-NP	O
1	1	CD	I-NP	O
neb	neb	NN	I-NP	O
NEB	NEB	NN	I-NP	O
Q3H	Q3H	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
during	during	IN	B-PP	O
wake	wake	NN	B-NP	O
hours	hour	NNS	I-NP	O
ALBUTEROL	ALBUTEROL	NN	I-NP	O
INHALER	INHALER	NN	I-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NN	I-NP	O
Q4H	Q4H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
Shortness	Shortness	NN	I-NP	O
of	of	IN	B-PP	O
Breath	Breath	NNP	B-NP	O
,	,	,	O	O
Wheezing	Wheezing	NNP	B-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
TFHC	TFHC	NN	B-NP	B-protein
per	per	IN	B-PP	O
TLHO	TLHO	NN	B-NP	O
team	team	NN	I-NP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
2/3/05	2/3/05	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
perclinic	perclinic	NN	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
prior	prior	JJ	B-NP	O
clinic	clinic	NN	I-NP	O
ALLERGY	ALLERGY	NN	I-NP	O
:	:	:	O	O
Cephalosporins	Cephalosporin	NNS	B-NP	O
,	,	,	O	O
ACE	ACE	NNP	B-NP	O
Inhibitor	Inhibitor	NNP	I-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Viral	Viral	JJ	B-NP	O
infection	infection	NN	I-NP	O
,	,	,	O	O
severe	severe	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
hypertension	hypertension	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
viral	viral	JJ	I-NP	O
URI	URI	NN	I-NP	O
,	,	,	O	O
pulmonary	pulmonary	JJ	B-NP	O
HTN	HTN	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
HTN	HTN	NN	I-NP	O
H/O	H/O	NN	I-NP	O
PUD	PUD	NN	I-NP	O
dm	dm	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
hypertension	hypertension	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
osa	osa	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
gerd	gerd	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
gastroesophageal	gastroesophageal	JJ	I-NP	O
reflux	reflux	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
None	None	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
SOB	SOB	NN	B-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
51	51	CD	B-NP	O
F	F	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
h/o	h/o	NN	I-NP	O
severe	severe	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
HTN	HTN	NN	I-NP	O
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
OSA	OSA	NN	B-NP	B-protein
,	,	,	O	O
obesity	obesity	NN	B-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
home	home	NN	I-NP	O
O2	O2	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
8L	8L	NN	I-NP	O
NC	NC	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
AH	AH	NN	I-NP	O
service	service	NN	I-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
until	until	IN	B-PP	O
about	about	IN	B-NP	O
one	one	CD	I-NP	O
week	week	NN	I-NP	O
ago	ago	RB	B-ADVP	O
,	,	,	O	O
having	have	VBG	B-VP	O
returned	return	VBN	I-VP	O
from	from	IN	B-PP	O
Pe	Pe	NNP	B-NP	O
Ale	Ale	NNP	I-NP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
experience	experience	VB	I-VP	O
dyspnea	dyspnea	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
and	and	CC	I-NP	O
chest	chest	NN	I-NP	O
tightness	tightness	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
reports	report	VBZ	B-VP	O
productive	productive	JJ	B-NP	O
cough	cough	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
greenish	greenish	JJ	I-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
rhinorrhea	rhinorrhea	NN	B-NP	O
,	,	,	O	O
sinus	sinus	NN	B-NP	O
tenderness	tenderness	NN	I-NP	O
,	,	,	O	O
N/V	N/V	NN	B-NP	O
,	,	,	O	O
malaise	malaise	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
palpitations	palpitation	NNS	B-NP	O
or	or	CC	O	O
radiating	radiate	VBG	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
day	day	NN	I-NP	O
PTA	PTA	NN	I-NP	O
,	,	,	O	O
VNA	VNA	NN	B-NP	B-protein
found	find	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
to	to	TO	B-VP	O
desat	desat	VB	I-VP	O
to	to	TO	B-PP	O
82	82	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
exertion	exertion	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
went	go	VBD	B-VP	O
to	to	TO	B-PP	O
Gas	Gas	NNP	B-NP	B-protein
Healthcare	Healthcare	NNP	I-NP	O
,	,	,	O	O
where	where	WRB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
SpO2	SpO2	NN	I-NP	O
of	of	IN	B-PP	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
8L	8L	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
NAD	NAD	NN	B-NP	O
on	on	IN	B-PP	O
CXR	CXR	NN	B-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
hospitalized	hospitalize	VBN	I-VP	O
in	in	IN	B-PP	O
September	September	NNP	B-NP	O
2005	2005	CD	I-NP	O
at	at	IN	B-PP	O
CRT	CRT	NN	B-NP	B-protein
with	with	IN	B-PP	O
simlar	simlar	JJ	B-NP	O
SOB	SOB	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
RHC	RHC	NN	I-NP	B-protein
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
PA	PA	NN	B-NP	O
pressures	pressure	NNS	I-NP	O
70-80	70-80	CD	B-NP	O
%	%	NN	I-NP	O
-LRB-	-LRB-	IN	B-PP	O
110/40/60	110/40/60	CD	B-NP	O
-65	-65	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
of	of	IN	B-PP	O
sytemic	sytemic	JJ	B-NP	O
pressures	pressure	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
MIBI	MIBI	NNP	I-NP	O
,	,	,	I-NP	O
negative	negative	JJ	I-NP	O
swallowing	swallow	VBG	I-NP	O
study	study	NN	I-NP	O
.	.	.	O	O

Since	Since	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
reports	report	VBZ	B-VP	O
being	be	VBG	I-VP	O
med	me	VBN	I-VP	O
compliant	compliant	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
diet	diet	NN	B-NP	O
compliant	compliant	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
weight	weight	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
stable	stable	JJ	B-ADJP	O
at	at	IN	B-PP	O
238	238	CD	B-NP	B-DNA
lbs	lb	NNS	I-NP	I-DNA
.	.	.	O	O

She	She	PRP	B-NP	O
feels	feel	VBZ	B-VP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
depression	depression	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
worse	worse	JJR	B-ADJP	O
of	of	IN	B-PP	O
late	late	RB	B-ADVP	O
.	.	.	O	O

ALL	ALL	NN	B-NP	O
:	:	:	O	O
ACEi	ACEi	NNP	B-NP	O
,	,	,	O	O
cephalopsporins	cephalopsporin	VBZ	B-VP	O
MEDS	MEDS	NNP	B-NP	O
:	:	:	O	O
K-Dur	K-Dur	NNP	B-NP	O
20	20	CD	I-NP	O
BID	BID	NNP	I-NP	O
,	,	,	O	O
Nexium	Nexium	NNP	B-NP	O
20	20	CD	I-NP	O
,	,	,	O	O
lasix	lasix	CD	B-NP	O
160	160	CD	I-NP	O
BID	BID	NN	I-NP	O
,	,	,	O	O
tracleer	tracleer	NN	B-NP	O
125	125	CD	I-NP	O
BID	BID	NNP	I-NP	O
,	,	,	I-NP	O
Glipizide	Glipizide	NNP	I-NP	O
80	80	CD	I-NP	O
BID	BID	NNP	I-NP	O
,	,	,	O	O
Coumadin	Coumadin	NNP	B-NP	O
5/7	5/7	CD	B-NP	O
.5	.5	CD	I-NP	O
,	,	,	O	O
ECASA	ECASA	NN	B-NP	B-DNA
81	81	CD	I-NP	I-DNA
,	,	,	O	O
Zoloft	Zoloft	NNP	B-NP	O
100	100	CD	I-NP	O
,	,	,	O	O
MVI	MVI	NNP	B-NP	O
,	,	,	O	O
Oceanspray	Oceanspray	NNP	B-NP	O
,	,	,	O	O
Ambien	Ambien	NNP	B-NP	O
10	10	CD	I-NP	O
QHS	QHS	NNP	I-NP	O
,	,	,	O	O
Ventavis	Ventavis	NNP	B-NP	O
nebs	neb	VBZ	B-VP	O
Q3H	Q3H	NN	B-NP	O
PE	PE	NN	I-NP	O
:	:	:	O	O
96.8	96.8	CD	B-NP	O
,	,	,	I-NP	O
83	83	CD	I-NP	O
,	,	,	I-NP	O
114/76	114/76	CD	I-NP	O
,	,	,	I-NP	O
97-98	97-98	CD	I-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
8L	8L	NN	B-NP	O
NC	NC	NN	I-NP	O
.	.	.	O	O

JVP	JVP	NN	B-NP	B-protein
14	14	CD	I-NP	I-protein
,	,	,	O	O
RRR	RRR	NN	B-NP	B-protein
,	,	,	O	O
loud	loud	JJ	B-NP	O
P2	P2	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
M.	M.	NNP	I-NP	O
CTA	CTA	NNP	I-NP	O
.	.	.	O	O

Obese	Obese	UH	B-INTJ	O
.	.	.	O	O

Labs	Lab	NNS	B-NP	O
:	:	:	O	O
K	K	NN	B-NP	O
3.5	3.5	CD	I-NP	O
,	,	,	O	O
Cr	Cr	NNP	B-NP	O
1.4	1.4	CD	I-NP	O
,	,	,	O	O
WBC	WBC	NNP	B-NP	B-cell_line
8.2	8.2	CD	I-NP	I-cell_line
,	,	,	O	O
CK/TNI	CK/TNI	NN	B-NP	O
neg	neg	NN	I-NP	O
,	,	,	O	O
BNP	BNP	NN	B-NP	B-protein
443	443	CD	I-NP	I-protein
.	.	.	O	O

****************	****************	SYM	O	O
Hospital	Hospital	NN	B-NP	O
Course	Course	NN	I-NP	O
******************	******************	SYM	B-NP	O
A/P	A/P	NN	I-NP	B-protein
51F	51F	NN	I-NP	I-protein
with	with	IN	B-PP	O
sever	sever	JJ	B-NP	O
pHTN	pHTN	NN	I-NP	O
,	,	,	O	O
OSA	OSA	NN	B-NP	B-protein
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
obesity	obesity	NN	B-NP	O
,	,	,	O	O
p/w	p/w	NN	B-NP	B-protein
SOB	SOB	NN	I-NP	I-protein
and	and	CC	O	O
URI-type	URI-type	JJ	B-NP	O
Sx	Sx	NN	I-NP	O
.	.	.	O	O

Near	Near	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
baseline	baseline	NN	I-NP	O
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

Pulm	Pulm	NN	B-NP	O
:	:	:	O	O
Severe	Severe	JJ	B-NP	O
pHTN	pHTN	NN	I-NP	O
with	with	IN	B-PP	O
very	very	RB	B-NP	O
elevated	elevated	JJ	I-NP	O
PA	PA	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
.	.	.	O	O

Likely	Likely	RB	B-NP	O
subjective	subjective	JJ	I-NP	O
SOB	SOB	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
context	context	NN	I-NP	O
of	of	IN	B-PP	O
viral	viral	JJ	B-NP	O
URI	URI	NN	I-NP	O
.	.	.	O	O

Cont	Cont	NNP	B-NP	O
Ilprost	Ilprost	NNP	I-NP	O
,	,	,	O	O
home	home	NN	B-NP	O
O2	O2	NN	I-NP	O
,	,	,	O	O
tracleer	tracleer	NN	B-NP	O
,	,	,	O	O
albuterol	albuterol	NN	B-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-NP	O
status	status	NN	I-NP	O
stable	stable	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	O	O
patient	patient	NN	B-NP	O
is	be	VBZ	B-VP	O
uneasy	uneasy	JJ	B-ADJP	O
with	with	IN	B-PP	O
going	go	VBG	B-VP	O
home	home	NN	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
so	so	RB	B-VP	O
will	will	MD	I-VP	O
stay	stay	VB	I-VP	O
-	-	HYPH	B-NP	O
stable	stable	JJ	I-NP	O
enought	enought	NN	I-NP	O
to	to	TO	B-VP	O
go	go	VB	I-VP	O
home	home	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
Recent	Recent	JJ	B-NP	O
ECHO	ECHO	NN	I-NP	O
,	,	,	O	O
Cath	Cath	NNP	B-NP	O
,	,	,	O	O
probably	probably	RB	B-NP	O
no	no	DT	I-NP	O
need	need	NN	I-NP	O
to	to	TO	B-VP	O
do	do	VB	I-VP	O
further	further	JJ	B-NP	O
w/u	w/u	NN	I-NP	O
.	.	.	O	O

ROMI	ROMI	NN	B-NP	O
by	by	IN	B-PP	O
serial	serial	JJ	B-NP	O
enzymes/EKG	enzymes/EKG	NN	I-NP	O
.	.	.	O	O

Continue	Continue	NNP	B-NP	O
Lasix	Lasix	NNP	I-NP	O
,	,	,	O	O
KCl	KCl	NNP	B-NP	O
,	,	,	O	O
ASA	ASA	NNP	B-NP	O
81	81	CD	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Psych	Psych	NN	B-NP	O
:	:	:	O	O
h/o	h/o	NN	B-NP	O
depression	depression	NN	I-NP	O
.	.	.	O	O

Inpatient	Inpatient	NN	B-NP	O
psych	psych	NN	I-NP	O
consult	consult	NN	I-NP	O
.	.	.	O	O

Cont	Cont	NNP	B-NP	O
.	.	.	O	O

zoloft	zoloft	RB	B-ADVP	O
,	,	,	O	O
ambien	ambien	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

DM	DM	NN	B-NP	O
:	:	:	O	O
Will	Will	NNP	B-NP	O
follow	follow	VBP	B-VP	O
FSBS	FSBS	NNP	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
Coumadin	Coumadin	NN	B-NP	O
for	for	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
microclots	microclot	NNS	I-NP	O
on	on	IN	B-PP	O
Bx	Bx	NN	B-NP	B-DNA
in	in	IN	B-PP	O
past	past	NN	B-NP	O
.	.	.	O	O

WIll	WIll	NNP	B-NP	O
increase	increase	VB	B-VP	O
Coumadin	Coumadin	NNP	B-NP	O
since	since	IN	B-PP	O
INR	INR	NNP	B-NP	O
1.9	1.9	CD	I-NP	O
,	,	,	O	O
recheck	recheck	VB	B-VP	O
QD	QD	NNP	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

FEN	FEN	NN	B-NP	O
:	:	:	O	O
low	low	JJ	B-NP	O
salt	salt	NN	I-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
fat	fat	NN	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
Likely	Likely	RB	B-NP	O
viral	viral	JJ	I-NP	O
URI	URI	NN	I-NP	O
.	.	.	O	O

BCx	BCx	NN	B-NP	B-protein
taken	take	VBN	B-VP	O
.	.	.	O	O

WIll	WIll	MD	B-VP	O
recheck	recheck	VB	I-VP	O
CXR	CXR	NN	B-NP	B-protein
if	if	IN	B-SBAR	O
clinically	clinically	RB	B-ADVP	O
warranted	warrant	VBN	B-VP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
GERD	GERD	NN	B-NP	O
,	,	,	O	O
nexium	nexium	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Call	Call	VB	B-VP	O
you	you	PRP	B-NP	O
doctor	doctor	NN	B-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
become	become	VBP	B-VP	O
more	more	RBR	B-ADJP	O
short	short	JJ	I-ADJP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Satisfactory	Satisfactory	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
EVERLY	EVERLY	NNP	B-NP	O
,	,	,	O	O
ARRON	ARRON	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OU82	OU82	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2/21/05	2/21/05	CD	I-NP	O
@	@	SYM	B-NP	O
07	07	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

